Latest News and Press Releases
Want to stay updated on the latest news?
-
Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue
-
Kaplan Fox & Kilsheimer LLP Reminds Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline
-
Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue
-
NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Eagle...
-
Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue
-
Kaplan Fox alerts investors of class action and upcoming deadline.
-
Kaplan Fox notifies investors of Class Action filed against Eagle Pharmaceuticals.
-
Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue
-
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Eagle Pharmaceuticals, Inc.
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Eagle Pharmaceuticals, Inc....